Evidence mapPaperPMID 42494516Full record

ArticleJBMR plus2026

Intensive, interdisciplinary pain treatment in fibrous dysplasia/McCune-Albright syndrome.

Camryn Berry, Edin Randall, Julie Shulman, Shealyn O'Donnell, Catherine E Stewart, Jen Christofferson, Kevin Zirko, Ana Gallotto, Eleanor Powell, Zachary S Peacock and 7 more

Abstract read
In one paragraph

Article in JBMR plus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Camryn BerryDepartment of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, United States.ORCID https://orcid.org/0009-0000-7373-5137
Edin RandallDepartment of Psychiatry and Behavioral Sciences, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, United States.ORCID https://orcid.org/0000-0001-5402-7215
Julie ShulmanDepartment of Physical Therapy and Occupational Therapy, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, United States.ORCID https://orcid.org/0000-0002-5530-9692
Shealyn O'DonnellDepartment of Physical Therapy and Occupational Therapy, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, United States.ORCID https://orcid.org/0009-0001-2873-4765
Catherine E StewartDepartment of Psychiatry and Behavioral Sciences, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, United States.ORCID https://orcid.org/0000-0002-1335-1454
Jen ChristoffersonDepartment of Psychiatry and Behavioral Sciences, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, United States.ORCID https://orcid.org/0000-0003-3892-9424
Kevin ZirkoDepartment of Physical Therapy and Occupational Therapy, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, United States.ORCID https://orcid.org/0009-0001-8506-7399
Ana GallottoDepartment of Physical Therapy and Occupational Therapy, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, United States.ORCID https://orcid.org/0009-0008-5162-4899
Eleanor PowellDepartment of Physical Therapy and Occupational Therapy, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, United States.ORCID https://orcid.org/0009-0001-8598-0700
Zachary S PeacockDepartment of Oral and Maxillofacial Surgery, Massachusetts General Hospital, Harvard School of Dental Medicine, Boston, MA 02114, United States.ORCID https://orcid.org/0000-0001-7683-3111
Amanda CaoDepartment of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, United States.ORCID https://orcid.org/0000-0003-0963-634X
Ella TrumperEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, United States.ORCID https://orcid.org/0009-0007-5511-2260
Boyu RenDepartment of Psychiatry, McLean Hospital, Harvard Medical School, Belmont, MA 02478, United States.ORCID https://orcid.org/0000-0002-5300-1184
Michael MannstadtEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, United States.ORCID https://orcid.org/0000-0003-0867-9778
Ingrid A HolmDivision of Genetics and Genomics, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, United States.ORCID https://orcid.org/0000-0003-4712-8821
Navil SethnaDepartment of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, United States.ORCID https://orcid.org/0000-0003-2200-9826
Jaymin UpadhyayDepartment of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, United States.ORCID https://orcid.org/0000-0002-8682-163X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pain in fibrous dysplasia/McCune-Albright syndrome (FD/MAS) remains inadequately treated. The pilot study was aimed to determine the feasibility (ie, completion, retention, and acceptability) and to explore the effectiveness of an intensive interdisciplinary pain treatment (IIPT) using a biopsychosocial approach in patients with FD/MAS. Five patients (4 females and 1 male; 22-30 yr old) with FD/MAS, with baseline pain severity of 4+ (0-10 scale) were enrolled. A 3-wk intervention (4 d/wk; 3-4 h/d) integrating psychological, physical, and occupational therapies was administered to patients. Study measures included patient-reported outcomes at treatment admission (week 0), discharge (week 3), and follow-up (week 15). Physician Global Assessments (PGA) at weeks 0 and 3 were also collected. All 5 patients completed the 3-wk intervention and follow-up assessment and reported a high degree of acceptability, appropriateness, and feasibility of the intervention. Average pain severity decreased after treatment, with mean changes of -3.0 and -3.2 points at weeks 3 and 15, respectively. Patients demonstrated improvements in pain interference, external pain expression (measured with the pain behavior scale), and pain catastrophizing. Trends of decreased anxiety and depression were observed. Overall health-related quality of life improved at treatment discharge, which was consistent with the PGA (ie, +2 to +3) scores. This pilot study demonstrates that IIPT was feasible and showed initial clinical benefit across multiple dimensions in a small cohort of patients with FD/MAS. Larger-scale, controlled trials are needed for further validation.

Indexed as

biopsychosocial modelchronic painfibrous dysplasiaintensive interdisciplinary pain treatmentMcCune–Albright syndrome

Identifiers

PMID42494516
PMCPMC13395099

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.